Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

Guselkumab versus Placebo for the Treatment of Psoriatic Arthritis Axial Disease in Bio-naive Participants Ended

2023-504716-15-00 Psoriatic Arthritis 2021-08-06
Rollover Study for Patients with Sickle Cell Disease who have Completed a prior Novartis-Sponsored Crizanlizumab Study Ended

2024-510734-41-00 Sickle cell disease 2021-06-10
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Ended

2024-518547-38-00 Patients who have undergone successful transcatheter bi 2021-05-12
Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, … Ended

2024-512844-40-00 Infertility 2021-04-20
NORTH-REG Dwell-Time Study Ended

2023-505936-37-00 Urothelial cancer 2021-02-03
Multicentre, open-label, randomised, two-arm, parallel-group, superiority study to assess bioavailability and practicability of Envarsus® co… Ended

2024-518033-28-00 Prophylaxis of transplant rejection in adult liver allo 2020-11-27
The USTAP CD trial USTekinumab in fistulising Perianal Crohn’s Disease: The USTAP CD study Ended

2023-503380-42-00 patient with moderate to severe Crohn's disease with at 2020-11-16
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients with Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung… Ended

2024-511185-37-00 Completely resected stage I or IIA non-squamous non-sma 2020-11-03
Investigation of Radium-223 dichloride (Xofigo), a treatment that gives off radiation that helps kill cancer cells, compared to a treatment … Ended

2023-505830-89-00 metastatic castrate resistant prostate cancer (mCRPC) 2020-08-05
CoCroS trial Ended

2024-516002-33-01 Crohn's disease 2019-12-23
The Effect of Benralizumab on Structural and Lung Function Changes in Patients with Severe Asthma Ended

2023-506614-40-00 Severe eosinophilic asthma 2019-11-11
This study will facilitate data collection of the long-term outcomes of pediatric subjects who have been treated in clinical trials with dab… Ended

2023-509276-42-00 Children and Adolescents with Cancers Harboring V600 mu 2019-10-30
A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged … Ended

2023-507678-42-00 Non Small Cell Lung Cancer; Medullary Thyroid Cancer; C 2019-10-24
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLA Ended

2024-510865-41-00 Urothelial cancer 2019-09-26
Effect of cladribine treatment on microglial activation in the CNS Ended

2024-519921-39-00 Multiple Sclerosis 2019-08-16
Finding the optimal dosing of recombinant FSH Ended

2024-517312-30-00 Subfertility in need of ICSI treatment 2019-06-19
IMPACT OF INTRAVENOUS IRON TREATMENT OF PREOPERATIVE ANEMIA IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERY DISEASE (IRONPAD) Ended

2024-514593-50-00 Anemia in patients with chronic ischemia of the lower l 2019-06-06
Evaluation of cortisone treatment in children suffering from acute facial nerve paralysis. Ended

2024-513430-37-00 Facial Nerve Palsy (Bells Palsy) 2019-06-01
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA (Dara-VM… Ended

2024-512049-17-00 Newly diagnosed MM patients >= 65 years old or ineligib 2018-09-05
Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial. Ended

2024-511890-30-03 Subfertility 2018-06-26
Hemodynamic safety of isobaric levobupivacaine versus isobaric bupivacaine for subarachnoid anesthesia in patients over 65 years old undergo… Ended

2025-520970-21-00 Hip fracture 2018-06-14
Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in pati… Ended

2023-508551-40-00 Coronary artery multi-vessel disease and left main sten 2018-06-08
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib Ended

2023-507329-40-00 1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 2017-09-28
Sustained treatment-free period in the course of a disease when symptoms become less severe in BCR-ABL+ chronic myeloid leukemia: a prospect… Ended

2023-510434-83-00 Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) 2016-10-17